ANSES: Composition of the Marketing authorisation monitoring Committee

As announced in our article of last 07 October, Members of the Marketing authorisation monitoring Committee have been appointed by the Order (‘Arrêté’) of 12 October 2015.

 

It consists of 11 appointed members:

  • As Chairman of the Committee: Mr. Michel GRIFFON,
  • As a professional for Health: Mr. Philippe QUENEL, Mrs. Laurie CORDIER,
  • As a product user: Mr. Bernard GUILLARD , Mr. Antoine LAMBERT, Mr. Denis VELUT,
  • As an agronomist: Mr. Franck DUROUEIX, Mr. Yves MONNET, Mr. François VILLENEUVE,
  • As a specialist for the Environment: Mr. Jean-Francois CHAUVEAU, Mr. Patrice MARCHAND.

 

News: Lynxee consulting receives French CIR (Research Tax credit) accreditation for 2015, 2016 and 2017

We are pleased to inform you that we have just received the French Research Tax Credit (CIR) accreditation for 2015, 2016 and 2017!

The ongoing and upcoming projects will thus be covered.

As a reminder, thanks to this approval, French clients can benefit from a tax credit of 30% of the total amount of R&D services eligible.

 

We remain at your disposal for any further information and quotation request.

  

Contact us! http://lynxee.consulting/en/contact/

 

To  download our accreditation: Agrement Lynxee_CIR_2015-2016-2017

  

EFSA : Overview of the assessment of endocrine disrupting properties for active substances in the EU Pesticides Peer Review

EFSA has published a technical report that gives an overview on the assessments of potential endocrine effects performed under Regulation No.1107/2009 since 2014 (15 Conclusions on new active substances and 26 on applications for renewal).

For 24 active substances, including 3 microbial pesticide active substances, the available information has not led to the detection of specific concerns, however in the case of two substances EFSA has recommended additional studies to confirm this conclusion. Hazard or risk based concerns have been identified from the available information for 15 substances. These concerns are related to the application of the interim criteria (based on the classification for reproductive and carcinogenic effects), the identification of relevant adverse effects which could be related to endocrine mechanisms or both.

The number of substances assessed to date is insufficient to conduct a statistical analysis however a wide range of options is already evident. For some substances the interim criteria were not met, but EFSA highlighted evidence extracted from the regulatory studies or scientific publications suggesting possible concerns, and recommended the need for additional studies to finalise the assessment of the potential endocrine mediated adverse effects.

A number of active substances meet the interim criteria for the identification of endocrine disrupting properties and possible endocrine-mediated adverse effects were observed in mammals, while in one case the first interim criterion is met although the scientific evidence suggests that it is unlikely the substance to be endocrine disruptor in mammals (false positive). In addition, for some substances the interim criteria were not meet, but EFSA considers that some adverse effects, identified from the regulatory studies or scientific publications, could be linked to endocrine mediated mechanisms (false negatives), and therefore EFSA highlighted possible concerns and recommended the need for additional studies to finalise the assessment of the endocrine effects.

With this approach, the EFSA Conclusions offer risk managers, stakeholders and citizens a transparent assessment of the available evidence, offering information that can be used to support the decision making process.

Assessment of endocrine disrupting properties in EFSA Conclusions

FRANCE – Anses : Functioning of the marketing authorisation monitoring Committee

The conditions of composition and functioning of Anses’ markeking authorisation monitoring Committee have just been established by French Decree No.2015-1184 of 25 September 2015, made under French Law for agriculture, food and forestry of 13 October 2014 (Article 51 of Law No. 2014-1170). Moreover, this Decree adds the monitoring system called ‘phytopharmacovigilance’ (PPV) to the list of the missions falling under the control of the Agency.

The  monitoring Committee will be constituted of 9 to 13 members whose appointment will be fixed for a 3-year period by an ‘Arrêté’. The list of members will be proposed by the Managing Director of the Agency. Members will be individuals recognised for their knowledge and skills in the areas of plant protection and crop fertilisers.

The  monitoring Committee may be consulted by  the Managing Director of the Agency on the following issues :

– the applicability of risk management measures in the authorisation context;

– the safety of use of products in relation to human and animal health and the environment ;

– The agronomic and socio-economic benefits of the different plant protection solutions available in line with the principles of agroecology, including biocontrol solutions;

– the use of the data collected within the framework of ‘phytopharmacovigilance’ (PPV);

– the identification of priority subjects regarding studies to be conducted in relation with the uses of plant protection products, adjuvants, fertilisers and growing media ;

– the identification of priority subjects regarding the control of the production, the formulation, the packaging and the labeling of plant protection products, adjuvants, fertilisers and growing media.

These measures will be applicable from the date of publication of the first list of members of the Committee of Approvals monitoring.


Décret n° 2015-1184

 

EUROPE: The EU Minor use Coordination Facility has started!

Mr Jeroen Meeussen started work on 1st September as coordinator for the new EU Minor Uses Coordination Facility.

The funding of this Coordination Facility was initiated further to the report from the Commission (REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the establishment of a European fund for minor uses in the field of plant protection products, Brussels, 18.2.2014 COM (2014) 82 final)  in order to gain solutions for “minor uses” in a more efficient way.

The EU and governments of France, Germany and the Netherlands have agreed to contribute funding to establish the Facility for the first three years. The Coordination Facility is hosted by EPPO in Paris. A Steering Group representing all funders will oversee its work.

The main task of the Coordination Facility will be to increase pest and disease control measures available for so called ‘minor crops’ and for minor pests on other crops for farmers and gardeners among all Member States.
Furthermore it is envisaged that the cooperation between the Coordination Facility and the ERANET on Integrated Pest Management (IPM ERANET) will result in more tools – chemical as well as non-chemical – becoming available for farmers in the field of pest and disease control.

 

More information on: http://www.eppo.int/News&Events/minor-use-facility.htm

 

Lynxee consulting’s team is at your disposal to help you with applications for minor uses.

Contact us! http://lynxee.consulting/en/contact/